 "Torrent Pharma Q3 results: PAT rises 14% to Rs 503 cr, misses estimates")
Torrent Pharmaceuticals on Friday said its profit after tax increased 14 per cent to Rs 503 crore for the third quarter ended December 2024, driven by robust performance in the domestic market.
The drug maker had reported a profit after tax (PAT) of Rs 443 crore in the October-December quarter of the last fiscal.
Its revenue jumped to Rs 2,809 crore in the third quarter compared to Rs 2,732 crore in the year-ago period, Torrent Pharma said in a statement.
The company said its India revenues rose by 12 per cent to Rs 1,581 crore, led by robust performance in focus therapies. ALSO READ: Godrej Consumer Products Q3: Profit drops 14% to Rs 498 cr, revenue up 3%
Similarly, Germany's revenues stood at Rs 282 crore for the third quarter, a growth of 4 per cent.
Its sales in the US, however, declined by 1 per cent to Rs 271 crore.
The company's board, which met on Friday, also approved an interim dividend of Rs 26 per equity share of Rs 5 each.
The dividend is expected to be paid on or around February 15, 2025, the company said.
Shares of the company on Friday ended 0.71 per cent down at Rs 3,243 apiece on BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%